JJJefferson Alessandro Schmitz Junior

Jefferson Alessandro Schmitz Junior

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jefferson Alessandro Schmitz Junior has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    USE OF CURCUMA LONGA L. AS A DRUG: A BIBLIOGRAPHIC ESSAY ABOUT THE MECHANISMS OF THE ACTION OF THE CONSTITUENTS OF THE SPECIES AGAINST PATHOLOGICAL PROCESSES.

    by Jefferson Alessandro Schmitz Junior, Arthur Guastala Engler, Valéria Luz Cunha Pint, Kassiely Zamarch, Filipe Andrich, Hélida Mara Magalhães, Meire Pereira de Souza Ferrari

    In the present work, the objective was to list the activities and mechanisms of action that classify as promising agents in the treatment of pathogenic processes the human species the constituents of the species Curcuma longa L. (or as it is popularly known, turmeric). Taking into account the phytotherapic characteristics of the species, it is suggested to use it as an alternative in the treatment of inflammatory processes caused by biological agents, or even in the treatment of diseases such as cancer and Alzheimer's. The studies addressed show antibacterial, antifungal, antitumor properties, and among others, as being attributed to the species mainly thanks to its main and major phenolic constituent: curcumin. The work was developed from studies in the scientific literature, through research platforms such as academic google and scielo, in addition to the use of books. Thanks to the results obtained, it is possible to classify the plant, which was already commonly used in some pathological processes, as a way to treat diseases and even as cosmetics. It is then suggested the study and development of drugs that address the use of curcumin in its composition, since the biological and chemical activities of this compound are proven to help in the treatment of some pathological processes.

  • Open Access

    ORIGANUM VULGARE ESSENTIAL OIL AND CARVACROL: NATURAL ALTERNATIVES AGAINST RESISTANT BACTERIA

    by Karolaine Bezerra, Isabela Carvalho Dos Santos, Gabriela Favero Espolador, Lídia Kazue Iukava, Suellen Regina Geraldo Azevedo, Jefferson Alessandro Schmitz Junior, Sandra Geane Pereira De Souza, Daniela Dib Gonçalves, Lidiane Nunes Barbosa

    Bacteria that are resistant to several antibiotics are a serious One Health problem, as new alternatives for treatment do not appear at the same speed. Thus, the aim of this work was to carry out a survey of studies involving the activity of the essential oil of O. vulgare and its isolated compound carvacrol on antibiotic-resistant bacteria. To this end, a qualitative review of the literature was carried out in the PubMed database from 2015 to 2020. Both for the essential oil and for the isolated compound, the inhibitory action extends to strains often associated with difficult-to-treat infections such as oxacillin and vancomycin-resistant Staphylococcus aureus, ?-lactamase-producing strains, carbapenemases, among others. The point that distinguishes the studies is the type of methodology used in the tests, with studies with carvacrol more directed towards mechanisms of molecular action and application in cells and animals, while those with oils are more preliminary. Although these substances have potential to control resistant bacteria, more research is needed to enable their use.

  • Open Access

    Bacteriophages’ action against mastitis-causing bactéria

    by Lidiane Nunes Barbosa, André Felipe Berto de Almada, Jefferson Alessandro Schmitz Junior, Marco Aurélio Del Vechio, Karolaine Bezerra, Gabriela Favero Espolador, Mariana Carvalho dos Santos, Lorena de Fatima Moretto, Isabela Carvalho dos Santos, Lisiane de Almeida Martins, et al.

    Mastitis is a breast tissue disease with a high incidence in dairy cows and implications ranging from the health of the animals to the economy of the sector. Although antibiotic therapy is widely used, the search for new perspectives in the management and treatment of this disease is necessary. Although phage research preceded the discovery of antibiotics, with the appearance of antibiotics and their efficiency in treating infections, phage therapy fell into disuse. However, phage therapy has now re-emerged as an alternative for combating multidrug-resistant bacteria. The relationship between phages, bacteria, and the immune system is unique, generating a wide range of opportunities, some of which have yet to be studied. Thus, the objective of this review was to analyze the use of bacteriophages in the control of bovine mastitis and its association with other natural products today. Phages have been shown to exert effective antibacterial and anti-biofilm activity, and their interactions with other substances of natural origin could be a viable path for treating disease. Despite being little explored, phages are already being considered as an alternative for treatment against the main bacterial agents of mastitis. In this review, the safety and future pathways of phage therapy are addressed in order to indicate points where research still needs to progress and the main advantages and difficulties in this area.